Literature DB >> 19183195

Involvement of macroautophagy in the caspase-independent killing of Burkitt lymphoma cell lines by rituximab.

Julie Turzanski, Ian Daniels, Andrew P Haynes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19183195     DOI： 10.1111/j.1365-2141.2008.07555.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  Rituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptors.

Authors:  Li-Hua Wang; Ning Wang; Xiao-Yu Lu; Bing-Chen Liu; Murali K Yanda; John Z Song; Helena M Dai; Yu-Liang Sun; Hui-Fang Bao; Douglas C Eaton; He-Ping Ma
Journal:  Biochim Biophys Acta       Date:  2011-12-13

Review 2.  Autophagy as a target for anticancer therapy.

Authors:  Filip Janku; David J McConkey; David S Hong; Razelle Kurzrock
Journal:  Nat Rev Clin Oncol       Date:  2011-05-17       Impact factor: 66.675

Review 3.  Targeting autophagy in lymphomas: a double-edged sword?

Authors:  Han Zhang
Journal:  Int J Hematol       Date:  2018-01-27       Impact factor: 2.490

Review 4.  Unfolded protein response to autophagy as a promising druggable target for anticancer therapy.

Authors:  Dong Hoon Suh; Mi-Kyung Kim; Hee Seung Kim; Hyun Hoon Chung; Yong Sang Song
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

Review 5.  Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma.

Authors:  Mojgan Djavaheri-Mergny; Sylvie Giuriato; Mario P Tschan; Magali Humbert
Journal:  Cells       Date:  2019-01-30       Impact factor: 6.600

6.  Autophagy as a target for cancer therapy: new developments.

Authors:  Jennifer S Carew; Kevin R Kelly; Steffan T Nawrocki
Journal:  Cancer Manag Res       Date:  2012-10-11       Impact factor: 3.989

7.  Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma.

Authors:  Li Hua Dong; Shu Cheng; Zhong Zheng; Li Wang; Yang Shen; Zhi Xiang Shen; Sai Juan Chen; Wei Li Zhao
Journal:  J Hematol Oncol       Date:  2013-07-18       Impact factor: 17.388

8.  Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model.

Authors:  E Decaup; C Jean; C Laurent; P Gravelle; S Fruchon; F Capilla; A Marrot; T Al Saati; F-X Frenois; G Laurent; C Klein; N Varoqueaux; A Savina; J-J Fournié; C Bezombes
Journal:  Blood Cancer J       Date:  2013-08-09       Impact factor: 11.037

Review 9.  The Therapeutic and Pathogenic Role of Autophagy in Autoimmune Diseases.

Authors:  Heng Yin; Haijing Wu; Yongjian Chen; Jianzhong Zhang; Min Zheng; Genhui Chen; Linfeng Li; Qianjin Lu
Journal:  Front Immunol       Date:  2018-07-31       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.